Julie Landry, MD
Obstetrics & Gynecology · Covington, LANPI 1114347515
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,124 of the $8,930 with a category attached, or 68.6%. Intuitive Surgical accounts for 83.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $7,750 and has fallen 99.2% since, to $64 in 2025. Among obstetrics & gynecology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $85.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- AbbVie$591
- Avion Pharmaceuticals$170
- Sumitomo Pharma America, Inc.$156
- Astellas Pharma US Inc$100
- Millicent US Inc$68
- plus $397 from 15 others
What the payments were for
- Travel & lodging$1,31515%
- Food & beverage$1,49017%
- Education$6,12469%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $7,446 |
| AbbVie | 35 | $591 |
| Avion Pharmaceuticals | 17 | $170 |
| Sumitomo Pharma America, Inc. | 9 | $156 |
| Astellas Pharma US Inc | 1 | $100 |
| Millicent US Inc | 4 | $68 |
| Bayer | 3 | $46 |
| Mylan Pharmaceuticals Inc. | 3 | $43 |
| Organon | 2 | $42 |
| Therapeuticsmd, Inc. | 3 | $40 |
| Mayne Pharma Commercial LLC | 2 | $38 |
| Pfizer | 2 | $32 |
| Exeltis, USA Inc. | 2 | $28 |
| Lupin Inc. | 2 | $28 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $14 |
| Amgen | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Coopersurgical, Inc. | 1 | $13 |
| Myovant Sciences Inc. | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- DA VINCI SP$1,315
How this compares
$8,930 in reported general payments places this provider in the 90th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 62 | $4,609 |
| PremproEstrogen,con/M-Progest Acet | 16 | $3,702 |
| ImvexxyEstradiol | 12 | $2,468 |
| Vivelle-DotEstradiol | 12 | $1,871 |
| ValacyclovirValacyclovir Hcl | 30 | $1,468 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,336 |
| Clobetasol Propionate | 22 | $499 |
| ProgesteroneProgesterone, Micronized | 12 | $163 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPrempro | $32 | $3,70216 claims |
| Therapeuticsmd, Inc.Imvexxy | $40 | $2,46812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 608 obstetrics & gynecology providers in Louisiana.
Other obstetrics & gynecology in Covington
- Jamie HymelCovington$7K
- Kelly BrewsterCovington$7K
- Daniel MokryCovington$6K
- Katherine WilliamsCovington$6K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Thomas PayneBaton Rouge$84K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.